Ensysce Biosciences, Inc. (ENSC)
0.4725
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 09:58
Ensysce Biosciences Debt to Equity Ratio : -0.2518 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2518 |
| March 31, 2026 | -0.6353 |
| December 31, 2025 | 0.0871 |
| September 30, 2025 | 0.3026 |
| June 30, 2025 | 0.1192 |
| March 31, 2025 | 0.0787 |
| December 31, 2024 | 0.0775 |
| September 30, 2024 | 0.0551 |
| June 30, 2024 | 0.2479 |
| March 31, 2024 | 0.0643 |
| December 31, 2023 | -2.647 |
| September 30, 2023 | 0.2382 |
| June 30, 2023 | 0.1109 |
| March 31, 2023 | 0.1146 |
| December 31, 2022 | -1.189 |
| September 30, 2022 | -1.473 |
| June 30, 2022 | -5.354 |
| March 31, 2022 | 5.464 |
| Date | Value |
|---|---|
| December 31, 2021 | -2.164 |
| September 30, 2021 | -46.71 |
| June 30, 2021 | 0.0851 |
| March 31, 2021 | 0.2429 |
| December 31, 2020 | -0.5407 |
| September 30, 2020 | 0.1074 |
| June 30, 2020 | 0.1121 |
| March 31, 2020 | 0.1642 |
| December 31, 2019 | 0.003 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 18.75 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.0127 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.957M |
| Total Liabilities (Quarterly) | 4.068M |
| Shareholders Equity (Quarterly) | -0.7817M |
| Current Ratio | 0.6031 |
| Net Debt Paydown Yield | 0.18% |